Mosapride (5HT4 agonist) in the treatment of blepharospasm
dc.contributor.author | Piyasena, I.N.A.P. | |
dc.contributor.author | Jayasinghe, J.A.C. | |
dc.date.accessioned | 2016-01-19T05:53:43Z | |
dc.date.available | 2016-01-19T05:53:43Z | |
dc.date.issued | 2014 | |
dc.identifier.citation | The Ceylon Medical Journal, 59(1):p.26-27 | |
dc.identifier.uri | https://dl.nsf.gov.lk/handle/1/21998 | |
dc.publisher | The Sri Lanka Medical Association:Colombo | |
dc.subject | Medical Sciences | |
dc.subject | Blepharospasm | |
dc.subject | Mosapride | |
dc.subject | 5HT4 agonist | |
dc.subject | Botulinum toxin | |
dc.title | Mosapride (5HT4 agonist) in the treatment of blepharospasm | |
dc.type | Article |